From GlobeNewswire: 2025-04-17 07:25:00

The market for injectable drug delivery devices is projected to reach $317.2 billion by 2029, with a CAGR of 7.9%. Factors driving this growth include the rising prevalence of chronic conditions and an aging population, technological advancements, and patient preference for self-administration.

The market is segmented by product type, usage type, route of administration, therapeutic application, end user, and region. The diabetes segment is expected to dominate the market in 2029, with North America holding the largest market share.

Key players in the market include AMGEN INC., ASTRAZENECA, BAXTER, B. BRAUN SE, and others. The field of injectable drug delivery is evolving with advanced systems like nanoparticles and liposomes, enhancing drug stability and bioavailability for sensitive formulations.

For further information or to purchase the report, contact [email protected]. BCC Research provides objective market analysis to help stakeholders make informed decisions and identify strategic opportunities in the global injectable drug delivery devices market.



Read more at GlobeNewswire: Injectable Drug Delivery Devices Market Set to Reach $317.2